By Jim Corbett, CEO, Emulate Drug discovery is at a crossroads. With nearly 90% of clinical trial candidates failing to reach FDA approval, the need for more predictive, human-relevant models […] The post Insights into the AVA™ Emulation System: Ushering in a New Era of Human-Relevant Drug Discovery appeared first on Emulate .